Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.37 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 6/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 4/20 | 0.35 |
| ▸ | FAAH | O00519 | 3/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552115 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL28919474 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL7967481 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL2729135 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL11432185 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL10993074 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL2957022 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL219970 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL1666274 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 | |
| SCHEMBL9651109 | 1.00 | CES2 (0.39) | CES2CA1GPR84CA2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | SYMRISE AG (DE) | 2019-04-04 | — | — | US | claimed |
| US-20100184816-A1 | Method for Reducing the Phytotoxicity of Azoles on Dicotyledonous Plants by Adding Additives | BAYER CROPSCIENCE AG (DE) | 2010-07-22 | — | — | US | claimed |
| EP-0402213-B1 | Process for the manufacture of polyvinyl butyral and resulting products | DU PONT (US) | 1994-09-21 | — | — | EP | claimed |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4186969-B1 | SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION | HENKEL AG & CO KGAA (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| WO-2002012423-A2 | DEODORISING TEXTILE TREATMENT AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-02-14 | — | — | WO | disclosed |
| US-20010031712-A1 | Surfactant Combination | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA (DE) | 2001-10-18 | — | — | US | disclosed |
| EP-0090142-B2 | PROCESS TO PRODUCE MOULDABLE VINYL CHLORIDE POLYMERS | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-12-05 | — | — | EP | disclosed |
| EP-0144614-B1 | PROCESS FOR PRODUCING VINYL CHLORIDE POLYMERS | HÜLS AKTIENGESELLSCHAFT (DE) | 1989-05-31 | — | — | EP | disclosed |
| EP-0108884-B1 | PROCESS FOR PRODUCING VINYL CHLORIDE POLYMERS | HÜLS AKTIENGESELLSCHAFT (DE) | 1987-06-10 | — | — | EP | disclosed |
| EP-0090142-B1 | PROCESS TO PRODUCE MOULDABLE VINYL CHLORIDE POLYMERS | HÜLS AKTIENGESELLSCHAFT (DE) | 1986-02-26 | — | — | EP | disclosed |
| EP-0144614-A2 | Process for producing vinyl chloride polymers | HÜLS AKTIENGESELLSCHAFT (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0108884-A1 | Process for producing vinyl chloride polymers | HÜLS AKTIENGESELLSCHAFT (DE) | 1984-05-23 | — | — | EP | disclosed |
| EP-0090142-A2 | Process to produce mouldable vinyl chloride polymers | HÜLS AKTIENGESELLSCHAFT (DE) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | TRPA1, TRPV2, NISCH | CA1 2904/4885CA2 737/4885CES2 326/4885 |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | KRT18, HCN4, COL14A1 | CA1 455/4885CA2 154/4885CES2 2862/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | CA1 4875/4885CA2 4525/4885CES2 2423/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | CA1 1939/4885CA2 1876/4885CES2 3801/4885 |
| US-20100184816-A1 | Method for Reducing the Phytotoxicity of Azoles on Dicotyledonous Plants by Adding Additives | AS3MT, STS, IPMK | CA1 198/4885CA2 9/4885CES2 2236/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | CA1 1298/4885CA2 332/4885CES2 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.